New York—Michael J. Fox recently reflected on the challenges posed by Parkinson’s disease in an interview, revealing the difficulties he faces while embracing his ongoing commitment to research and advocacy. The 65-year-old actor, a well-known face in Hollywood, was recognized with the prestigious Lasker~Bloomberg Public Service Award on Sept. 9, 2026, underscoring his dedication to advancing Parkinson’s research since his diagnosis in 1991.
Despite acknowledging that living with the disease has become increasingly difficult over the years, Fox expressed gratitude for his platform to promote awareness and to support research efforts aimed at curing this progressive nervous system disorder. “I’m privileged to commit my time and energy to bringing everything I’ve got to help cure this disease,” he stated, signaling his resolve in the face of adversity.
Parkinson’s disease, a progressive disorder, manifests uniquely in each individual, often causing symptoms like tremors, stiffness, and communication challenges. Fox, who publicly revealed his diagnosis in 1998, has faced a range of symptoms throughout his journey, which initially led a doctor to predict limited acting opportunities ahead for him. Defying those early limitations, Fox’s passionate advocacy and resilience have significantly altered perceptions surrounding the disease.
The Lasker Foundation praised Fox not only for his personal fight against Parkinson’s but also for his role in transforming research paradigms by erasing stigma and fostering collaboration among scientists and health advocates. In accepting the award, Fox acknowledged the collective efforts of those dedicated to mitigating the impact of the disease, stressing that the honor reflects the hard work of many, including researchers, patients, and families.
Since its establishment in 2000, The Michael J. Fox Foundation for Parkinson’s Research has contributed over $3 billion to research globally. The foundation’s initiatives, notably including partnerships with organizations like the Aligning Science Across Parkinson’s initiative, have been instrumental in securing 23 new drug approvals in the previous ten years, with more treatments advancing through clinical trials. In further advocacy efforts, Fox testified before Congress in 1999, successfully pushing for increased federal funding for Parkinson’s research, leading to the passage of the National Plan to End Parkinson’s Act in July 2024.
In recent years, Fox has made a notable return to television, reprising his role in Apple TV’s series “Shrinking,” where he portrayed a character grappling with the same challenges he faces in real life. This experience has reinvigorated his passion for acting and provided him a unique space to engage with audiences authentically. His performance earned him a nomination for an Emmy Award for outstanding guest actor, highlighting his continued influence within the industry.
On Sept. 14, Fox was honored with the Bob Hope Humanitarian Award during the 78th Emmy Awards, where he reflected on his early reluctance to share his diagnosis publicly. Recognizing the support he has received from fans and the community, he reaffirmed his commitment to finding a cure and emphasized the urgency of ongoing research.
In a bid to raise further funds for Parkinson’s research, Fox announced a new campaign aiming for $2.5 billion, called “All Grit. No Quit.” This initiative has already secured more than $1.75 billion and has expanded its community to nearly four million individuals, including 1.2 million donors. He described the foundation’s growth and the fervor of its supporters as a testament to the shared hope for a future without Parkinson’s.
Renowned scientist Randy Schekman, a Nobel laureate who nominated Fox for the Lasker Award, highlighted the actor’s profound impact on the scientific community, noting that his dedication has played a significant role in redefining the landscape of Parkinson’s disease research and advocating for those affected by it.